[144] ACI Worldwide, Inc. SEC Filing
Rhea-AI Filing Summary
ACI Worldwide, Inc. (NASDAQ: ACIW) has received a Form 144 filing indicating that an unidentified affiliate intends to sell 4,500 common shares through Morgan Stanley Smith Barney on or about 18 June 2025. At the recent market price used in the filing, the transaction is valued at roughly $200,970.
The shares represent approximately 0.004 % of the company’s 104.9 million shares outstanding and were originally acquired as restricted stock on 2 June 2025. The filer reports no other sales in the past three months and affirms the customary representation that no undisclosed material adverse information is known.
Form 144 notices are routine compliance documents required before affiliates sell restricted or control securities. Given the small size relative to ACIW’s float, this proposed sale is unlikely to have a meaningful effect on liquidity, ownership structure, or share price.
Positive
- None.
Negative
- None.
Insights
TL;DR: 4,500-share Form 144 for ACIW; size trivial, no valuation impact expected.
The filing signals an affiliate’s plan to sell less than five-thousand shares, worth about $201k, versus a market capitalization measured in the billions. Such a transaction neither alters the supply–demand balance nor signals broad insider sentiment. No pricing discount or accelerated book-build is involved; therefore, trading liquidity easily absorbs the volume. From a portfolio construction standpoint, the event is immaterial and does not warrant position adjustment.
TL;DR: Routine insider sale notice; governance implications minimal.
Form 144 compliance demonstrates that the insider is following SEC resale restrictions, including the Rule 144 holding period and information disclosure obligations. Absence of prior three-month sales limits aggregation concerns. No red flags—such as simultaneous large-scale disposals or pattern selling—are evident. Governance watchers should monitor cumulative sales but, on a standalone basis, this isolated filing poses no governance or signaling risk.